Now showing 1 - 1 of 1
No Thumbnail Available
Biosynthesis of amphotericin derivatives lacking exocyclic carboxyl groups
2005-08-03, Carmody, Maria, Murphy, Barry, Byrne, Barry, Power, Patrick, Rai, Dilip K., Rawlings, Bernard, Caffrey, Patrick
Amphotericin B is a medically important antifungal antibiotic that is also active against human immunodeficiency virus, Leishmania parasites, and prion diseases. The therapeutic use of amphotericin B is restricted by severe side effects that can be moderated by liposomal formulation or structural alteration. Chemical modification has shown that suppression of charge on the exocyclic carboxyl group of amphotericin B substantially reduces toxicity. We report targeted deletions of the amphN cytochrome P450 gene from the chromosome of the amphotericin-producing bacterium Streptomyces nodosus. The mutant strains produced amphotericin analogues in which methyl groups replace the exocyclic carboxyl groups. These compounds retained antifungal activity and had reduced hemolytic activity.